Non-Myeloablative Conditioning Targeting Host Immunosuppression Is Successful in Matched Sibling Donor Stem Cell Transplantation for Hemoglobinopathies in Children
Allison A. King(The University of Texas Health Science Center at Houston), Shalini Shenoy(Washington University in St. Louis), Joel A. Brochstein(Cohen Children's Medical Center), Geoff D.E. Cuvelier(CancerCare Manitoba), Jennifer Willert(Unknown), Andrew L. Gilman(Gene Therapy Laboratory), Lisa Murray(Washington University in St. Louis), Indira Sahdev(Cohen Children's Medical Center), Kimberly A. Kasow(University of North Carolina at Chapel Hill), Alfred P. Gillio(University Medical Center), Naynesh Kamani(American Association of Blood Banks), Michael Grimley(Cincinnati Children's Hospital Medical Center), Jacqueline Dioguardi(Children's National), Allistair Abraham(Children's National), Paul R. Haut(Indiana University Health), Lolie C. Yu(Louisiana State University), Martin Andreánsky(University of Miami Health System), Sonali Chaudhury(Northwestern University), Eric P. Hanson(Washington University in St. Louis), Dorothea Douglas(University of Arizona), Jignesh Dalal(Rainbow Babies & Children's Hospital), Akshat Jain(Cohen Children's Medical Center), Ka Wah Chan(Methodist Children’s Hospital), Roberta H. Adams(Mayo Clinic in Arizona), Nancy Bunin(University of Iowa), Gregory A. Hale(Johns Hopkins University), Eric Anderson(University of California San Diego)
Cited by 1
Related Papers
Long-Term Outcomes Among Adult Survivors of Childhood Central Nervous System Malignancies in the Childhood Cancer Survivor Study
|JNCI Journal of the National Cancer Institute|2009|530
Hematopoietic stem cell transplantation in thalassemia major and sickle cell disease: indications and management recommendations from an international expert panel
|Haematologica|2014|389
Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure
|Blood|2016|333
Outcome of unrelated donor bone marrow transplantation in 40 children with Hurler syndrome
|Blood|1996|318
Phase II Trial of Costimulation Blockade With Abatacept for Prevention of Acute GVHD
|Journal of Clinical Oncology|2021|255